Solving the Rare Disease Launch Paradox: Using Pre-Launch Planning and Partnership to Create

Emerging biopharma companies preparing for a first rare disease launch must balance speed, capital constraints and regulatory uncertainty while building the capabilities required for commercial success. This POV examines five critical launch success factors, including pre-launch preparation, governance, integrated infrastructure, organizational alignment and coordinated execution. Through a real-world launch example, readers will learn how an integrated partnership model can accelerate readiness, reduce operational complexity, preserve strategic control and support patient access from day one.